BioAscent will be attending the RSC-BMCS Conformational Design in Drug Discovery symposium on 2 March at the GSK Conference Centre, Stevenage.

The symposium will bring together industry colleagues to discuss ligand rigidification and physicochemical optimisation strategies for protein-protein interaction inhibitors, PROTACs, molecular glues, antibody-drug-conjugate payloads and other new modalities.

The BioAscent team will be available to meet fellow delegates throughout the symposium. If you’d like to arrange a meeting, please get in touch by emailing info@bioascent.com.

Find out more about the symposium here.